Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Valuing the Endangered Species Antirrhinum lopesianum: Neuroprotective Activities and Strategies for in vitro Plant Propagation.
Efficacy and safety of fingolimod (FTY720) in patients with relapsing-remitting multiple sclerosis (FREEDOMS II)
Volumetric MRI assessment of brain and spinal cord in finnish twins discordant for multiple sclerosis.
Immune-mediated inflammatory diseases: progress in molecular pathogenesis and therapeutic strategies.
Increased thyroid autoimmunity among women with multiple sclerosis in the postpartum setting.
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS.
Cerebral vein changes in relapsing-remitting multiple sclerosis demonstrated by three-dimensional enhanced T (2) (*) -weighted angiography at 3.0 T.
Shared environmental effects on multiple sclerosis susceptibility: conflicting evidence from twin studies.
Teriflunomide and its mechanism of action in multiple sclerosis.
The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review.
Minimal supportive treatment in natalizumab-related PML in a MS patient.
Worsening essential tremor following deep brain stimulation: disease progression versus tolerance.
Erratum to: A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Biological monitoring of IFN-β therapy in Multiple Sclerosis.
Polysialic acid as an antigen for monoclonal antibody HIgM12 to treat multiple sclerosis and other neurodegenerative disorders.
Level of education and multiple sclerosis risk after adjustment for known risk factors: The EnvIMS study.
Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.
Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications.
The role of optical coherence tomography (OCT) in optic neuritis (ON).
Lack of association between CD226 genetic variants and inflammatory demyelinating diseases in Korean population.
Multiple sclerosis.
Neuroimmunology: Aquaporin-4-antibody-seronegative neuromyelitis optica is less common than previously thought.
Pages
« first
‹ previous
…
436
437
438
439
440
441
442
443
444
…
next ›
last »